Evaluation of the predictive and prognostic potential of blood immune cell profiles in metastatic cancer patients treated with immune checkpoint inhibitors

This work was supported by State Research Funding for university-level health Research, Kuopio University Hospital, Wellbeing Service County of North Savo (project number 5654210), Cancer Foundation of Finland, Finnish Cultural Foundation, Cancer Society of North Savo, The Finnish Medical Foundation sr (7074), Cancer Society of North Savo (20240026), and the Paavo Koistinen Foundation (202300011). The funding sources had no involvement in the study design, data collection, analysis, interpretation of the data, or the writing and editing of the manuscript.